Stay updated on Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Removed the 'Multiple myeloma' content and the related MedlinePlus Genetics links from the page.
    Difference
    0.1%
    Check dated 2026-03-04T23:37:34.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Related topics now include Multiple myeloma and a MedlinePlus Genetics link.
    Difference
    0.1%
    Check dated 2026-02-25T18:52:28.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page no longer displays the disease name 'Multiple myeloma' or its related topics. This reduces disease context and discoverability for the trial.
    Difference
    0.1%
    Check dated 2026-02-18T16:34:33.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Minor metadata updates: 'Multiple myeloma' added as a related topic and 'MedlinePlus Genetics' linked; page revision updated to v3.4.2, with the old funding notice and v3.4.1 removal. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T14:21:43.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added a government funding and NIH Clinical Center status notice and updated the site revision to v3.4.1; removed reference to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-04T10:41:39.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Added a glossary display, added Last Update Submitted that Met QC Criteria, and updated footer notes to No FEAR Act Data with revision to v3.4.0. Removed the term 'Multiple Myeloma' and related topics such as MedlinePlus Genetics, and adjusted capitalization for No FEAR Act data and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T06:35:38.000Z thumbnail image

Stay in the know with updates to Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Daratumumab With Standard Myeloma Regimens Clinical Trial page.